| Metric | Q3 2026 | Q3 2025 |
|---|---|---|
| Revenue | 3,471.0 | 3,339.0 |
| Gross profit | 1,105.0 | 1,026.0 |
| Profit before tax | 160.0 | 134.0 |
| Net income | 119.0 | 101.0 |
| EPS (diluted, $ a share) | $1.06 | $0.84 |
A dash means the filing did not report that period. Growth is not shown when either period was a loss. Figures from the filing's XBRL data.
| Net income, year on year | +17.8% |
|---|---|
| Revenue, year on year | +4.0% |
| Gross margin | 31.8% |
| Operating margin | 5.6% |
10-Q filed with the SEC, NASDAQ: HSIC. Figures from the filing's XBRL data; summary written with AI assistance from the filing.
Henry Schein Inc: key numbers
- Share price
- $84.96Close, Nov 16
- Market cap
- $9.39B
- Shares outstanding
- 110.54MLatest SEC cover page
- Sector
- Trade & Services
- Industry
- Wholesale-Medical, Dental & Hospital Equipment & SuppliesSIC 5047
Today's reference numbers, updated daily. Not a valuation or a recommendation.
More from Henry Schein Inc
All →Henry Schein Investor Meeting
Henry Schein announced a voluntary change to its non-GAAP financial reporting to exclude acquisition-related remeasurement gains starting in Q4 2026. Consequently, the company updated its FY2026 non-GAAP diluted EPS guidance to $5.42-$5.48 from $5.50-$5.56 to reflect this accounting adjustment, with no change to its underlying business outlook.
Henry Schein Financial Results
Henry Schein reported Q3 2026 financial results with total sales of $3.5 billion, representing 4.0% growth driven by strong U.S. dental merchandise volume. The company raised its full-year 2026 non-GAAP diluted EPS guidance to a range of $5.50 to $5.56, citing strong operating performance and net tariff refund benefits.
- Term
- Q3 2026
“We delivered another strong quarter that increases our confidence in the momentum we are building at Henry Schein. I am very pleased with the U.S. dental merchandise sales growth of 8.6% driven primarily by volume in a stable market and our 19% adjusted earnings per share growth.”
Fred Lowery, Chief Executive Officer of Henry Schein
“Our strategy is translating into stronger financial results. We are gaining share in key businesses, improving our portfolio mix, maintaining a disciplined approach to capital allocation, and realizing the benefits of our value creation initiatives.”
Fred Lowery, Chief Executive Officer of Henry Schein
Henry Schein Executive Compensation
Henry Schein appointed Emmanuel Caprais as Senior Vice President and CFO, effective November 4, 2026, succeeding Ronald N. South who will transition to a Senior Advisor role. Caprais will receive an annual base salary of $750,000, a target bonus of $750,000, and a 2027 long-term incentive award estimated at $2.5 million.
Henry Schein $1.25B Debt Financing with JPMorgan Chase Bank, N.A.
Henry Schein, Inc. entered into a Fourth Amended and Restated Revolving Credit Agreement, increasing its aggregate revolving credit commitments from $1 billion to $1.25 billion. The amendment extends the facility's termination date to September 19, 2031, and modifies certain financial definitions and covenants. The funds are intended for general corporate purposes, including working capital, capital expenditures, stock repurchases, debt refinancing, and potential acquisitions.
- Value
- $1.25B
- Counterparty
- JPMorgan Chase Bank, N.A.
- Term
- through September 19, 2031